EATG » Cure

Cure

New light shed on HIV-1 reservoir reductions after stem cell transplant

Several factors underlie a profound reduction in the HIV-1 reservoir in patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT) for hematologic disease, researchers report. Previous studies have found substantial…

Latest issue of Journal of Virus Eradication now online

The Journal of Virus Eradication provides a specialist, open-access forum and fast-track pathway to publish work in the rapidly developing field of virus eradication, particularly of HIV, HBV and HCV.…

Combination therapy targets latent reservoir of HIV

Findings represent potential strategy to overcome critical barrier to a cure for HIV/AIDS BIDMC Research Briefs showcase groundbreaking scientific advances that are transforming medical care. With more than 35 million…

Vedolizumab could be used to target latent HIV harboring in gut

Vedolizumab, a first-line treatment for inflammatory bowel disease that targets the alpha4beta7 protein, might be an important tool in the search for a cure for HIV, according to research published…

Largest study of ‘post-treatment controllers’ reveals clues about HIV remission

Some HIV patients maintain low viral loads after stopping treatment; early treatment and HIV reservoir size may be the keys Most HIV patients need to take daily anti-retroviral therapy -…

Researchers date ‘hibernating’ HIV strains, advancing BC’s leadership in HIV cure research

New findings bring Canada's largest HIV research, treatment & education organization, the British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), into the area of HIV vaccine and cure research [Vancouver,…

AIDS 2018 HIV cure research highlights

The 22nd International AIDS Conference took place in Amsterdam from July 23–27, 2018. Here is a summary of key highlights on HIV cure-related research from the conference.  

HIV i-Base, HTB: AIDS 2018 reports

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This issue of HTB includes the first reports from the 22nd International AIDS Conference (AIDS 2018) that was…

AIDS 2018 coverage: NATAP, MedPage Today

The 22nd International AIDS Conference (AIDS 2018) took place in Amsterdam, the Netherlands, from 23 to 27 July 2018. NATAP reports: Rates of kidney and bone disease--and multiple comorbidities--rising in…

AIDS 2018: Fauci: HIV remission free of antiretroviral therapy is a feasible goal

NIAID director will give special session lecture at AIDS 2018 Conference. Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S.…

1 2 3 17